STERIS (STE) Stock Forecast & Price Target $227.14 +4.14 (+1.86%) Closing price 03/31/2025 03:59 PM EasternExtended Trading$226.68 -0.46 (-0.20%) As of 03/31/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STERIS - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 5 Analyst RatingsSell0Hold1Buy4 Based on 5 Wall Street analysts who have issued ratings for STERIS in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 5 analysts, 1 has given a hold rating, and 4 have given a buy rating for STE. Consensus Price Target $258.7513.92% Upside According to the 5 analysts' twelve-month price targets for STERIS, the average price target is $258.75. The highest price target for STE is $265.00, while the lowest price target for STE is $240.00. The average price target represents a forecasted upside of 13.92% from the current price of $227.14. Get the Latest News and Ratings for STE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for STERIS and its competitors. Enter your email to sign up for newsletter Sign Up STE Analyst Ratings Over TimeTypeCurrent Forecast4/1/24 to 4/1/251 Month Ago3/2/24 to 3/2/253 Months Ago1/2/24 to 1/1/251 Year Ago4/2/23 to 4/1/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy4 Buy rating(s)4 Buy rating(s)4 Buy rating(s)3 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$258.75$258.75$262.50$239.60Forecasted Upside13.92% Upside18.03% Upside27.70% Upside8.40% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads STE Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History STE Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table STERIS Stock vs. The CompetitionTypeSTERISMedical CompaniesS&P 500Consensus Rating Score 2.80 2.82 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside13.92% Upside19,270.47% Upside19.03% UpsideNews Sentiment RatingVery Positive NewsSee Recent STE NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/6/2025JMP Securities2 of 5 starsReni BenjaminSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$265.00 ➝ $265.00+17.96%2/6/2025Stephens4 of 5 starsJacob JohnsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$240.00 ➝ $240.00+7.49%2/3/2025Piper Sandler2 of 5 starsJ. BednarSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$260.00 ➝ $265.00+21.26%11/8/2024Needham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingHold9/3/2024KeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$255.00 ➝ $265.00+9.11%12/4/2023Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetEqual Weight ➝ Equal Weight$225.00 ➝ $215.00+5.65%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:40 AM ET. Should I Buy STERIS Stock? STE Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, March 27, 2025. Please send any questions or comments about these STERIS pros and cons to contact@marketbeat.com. STERIS Bull Case Here are some ways that investors could benefit from investing in STERIS plc: Current stock price is $223.03, which is positioned well within its 52-week range of $197.82 to $248.24, indicating potential for growth. STERIS plc has a strong market capitalization of $21.91 billion, suggesting stability and the ability to invest in growth opportunities. The company reported a net margin of 8.66%, reflecting efficient management and profitability, which can lead to higher returns for investors. Recent analyst ratings show a consensus of "Moderate Buy" with a price target of $258.75, indicating positive sentiment and potential for price appreciation. STERIS plc has a solid dividend yield of 1.02% with a payout ratio of 48.41%, providing investors with a steady income stream while retaining a portion of earnings for reinvestment. STERIS Bear Case Investors should be bearish about investing in STERIS plc for these reasons: The stock has a high price-to-earnings (P/E) ratio of 47.35, which may indicate that the stock is overvalued compared to its earnings, posing a risk for new investors. Recent earnings results showed a slight miss on EPS estimates, reporting $2.32 against a consensus of $2.33, which could raise concerns about future performance. Despite a strong market cap, the company has a debt-to-equity ratio of 0.32, which, while manageable, indicates some reliance on debt that could affect financial stability in adverse conditions. Market volatility, as indicated by a beta of 0.92, suggests that the stock may not be as stable as desired, potentially leading to fluctuations in investment value. Institutional investors hold 94.69% of the company's stock, which may limit the influence of retail investors and could lead to less favorable conditions for smaller shareholders. STE Forecast - Frequently Asked Questions What is STERIS's forecast for 2025? According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for STERIS is $258.75, with a high forecast of $265.00 and a low forecast of $240.00. Should I buy or sell STERIS stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There is currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STE shares. Does STERIS's stock price have much upside? According to analysts, STERIS's stock has a predicted upside of 13.92% based on their 12-month stock forecasts. What analysts cover STERIS? STERIS has been rated by research analysts at JMP Securities, Piper Sandler, and Stephens in the past 90 days. Do Wall Street analysts like STERIS more than its competitors? Analysts like STERIS less than other "medical" companies. The consensus rating score for STERIS is 2.80 while the average consensus rating score for "medical" companies is 2.82. Learn more on how STE compares to other companies. Stock Forecasts and Research Tools Related Companies BDX Stock Forecast EW Stock Forecast IDXX Stock Forecast RMD Stock Forecast DXCM Stock Forecast PODD Stock Forecast BAX Stock Forecast HOLX Stock Forecast GMED Stock Forecast MASI Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:STE) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Share STERIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STE Stock Free STE Stock Alerts